This report contains market size and forecasts of Liposomes Drug Delivery in global, including the following market information:
Global Liposomes Drug Delivery Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Liposomes Drug Delivery Market Sales, 2016-2021, 2022-2027, (K Vial)
Global top five Liposomes Drug Delivery companies in 2020 (%)
The global Liposomes Drug Delivery market was valued at 3924.2 million in 2020 and is projected to reach US$ 6230 million by 2027, at a CAGR of 12.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liposomes Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liposomes Drug Delivery Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Vial)
Global Liposomes Drug Delivery Market Segment Percentages, By Type, 2020 (%)
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Global Liposomes Drug Delivery Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Vial)
Global Liposomes Drug Delivery Market Segment Percentages, By Application, 2020 (%)
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
Global Liposomes Drug Delivery Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Vial)
Global Liposomes Drug Delivery Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liposomes Drug Delivery revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Liposomes Drug Delivery revenues share in global market, 2020 (%)
Key companies Liposomes Drug Delivery sales in global market, 2016-2021 (Estimated), (K Vial)
Key companies Liposomes Drug Delivery sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau Group
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Liposomes Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liposomes Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liposomes Drug Delivery Overall Market Size
2.1 Global Liposomes Drug Delivery Market Size: 2021 VS 2027
2.2 Global Liposomes Drug Delivery Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Liposomes Drug Delivery Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Liposomes Drug Delivery Players in Global Market
3.2 Top Global Liposomes Drug Delivery Companies Ranked by Revenue
3.3 Global Liposomes Drug Delivery Revenue by Companies
3.4 Global Liposomes Drug Delivery Sales by Companies
3.5 Global Liposomes Drug Delivery Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Liposomes Drug Delivery Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Liposomes Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 Liposomes Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 Liposomes Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 Liposomes Drug Delivery Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Liposomes Drug Delivery Market Size Markets, 2021 & 2027
4.1.2 Liposomal Doxorubicin
4.1.3 Liposomal Amphoteracin B
4.1.4 Liposomal Paclitaxel
4.1.5 Others
4.2 By Type - Global Liposomes Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Liposomes Drug Delivery Revenue, 2016-2021
4.2.2 By Type - Global Liposomes Drug Delivery Revenue, 2022-2027
4.2.3 By Type - Global Liposomes Drug Delivery Revenue Market Share, 2016-2027
4.3 By Type - Global Liposomes Drug Delivery Sales & Forecasts
4.3.1 By Type - Global Liposomes Drug Delivery Sales, 2016-2021
4.3.2 By Type - Global Liposomes Drug Delivery Sales, 2022-2027
4.3.3 By Type - Global Liposomes Drug Delivery Sales Market Share, 2016-2027
4.4 By Type - Global Liposomes Drug Delivery Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Liposomes Drug Delivery Market Size, 2021 & 2027
5.1.2 Fungal Infection Therapy
5.1.3 Cancer & Tumor Therapy
5.1.4 Others
5.2 By Application - Global Liposomes Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Liposomes Drug Delivery Revenue, 2016-2021
5.2.2 By Application - Global Liposomes Drug Delivery Revenue, 2022-2027
5.2.3 By Application - Global Liposomes Drug Delivery Revenue Market Share, 2016-2027
5.3 By Application - Global Liposomes Drug Delivery Sales & Forecasts
5.3.1 By Application - Global Liposomes Drug Delivery Sales, 2016-2021
5.3.2 By Application - Global Liposomes Drug Delivery Sales, 2022-2027
5.3.3 By Application - Global Liposomes Drug Delivery Sales Market Share, 2016-2027
5.4 By Application - Global Liposomes Drug Delivery Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Liposomes Drug Delivery Market Size, 2021 & 2027
6.2 By Region - Global Liposomes Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Liposomes Drug Delivery Revenue, 2016-2021
6.2.2 By Region - Global Liposomes Drug Delivery Revenue, 2022-2027
6.2.3 By Region - Global Liposomes Drug Delivery Revenue Market Share, 2016-2027
6.3 By Region - Global Liposomes Drug Delivery Sales & Forecasts
6.3.1 By Region - Global Liposomes Drug Delivery Sales, 2016-2021
6.3.2 By Region - Global Liposomes Drug Delivery Sales, 2022-2027
6.3.3 By Region - Global Liposomes Drug Delivery Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Liposomes Drug Delivery Revenue, 2016-2027
6.4.2 By Country - North America Liposomes Drug Delivery Sales, 2016-2027
6.4.3 US Liposomes Drug Delivery Market Size, 2016-2027
6.4.4 Canada Liposomes Drug Delivery Market Size, 2016-2027
6.4.5 Mexico Liposomes Drug Delivery Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Liposomes Drug Delivery Revenue, 2016-2027
6.5.2 By Country - Europe Liposomes Drug Delivery Sales, 2016-2027
6.5.3 Germany Liposomes Drug Delivery Market Size, 2016-2027
6.5.4 France Liposomes Drug Delivery Market Size, 2016-2027
6.5.5 U.K. Liposomes Drug Delivery Market Size, 2016-2027
6.5.6 Italy Liposomes Drug Delivery Market Size, 2016-2027
6.5.7 Russia Liposomes Drug Delivery Market Size, 2016-2027
6.5.8 Nordic Countries Liposomes Drug Delivery Market Size, 2016-2027
6.5.9 Benelux Liposomes Drug Delivery Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Liposomes Drug Delivery Revenue, 2016-2027
6.6.2 By Region - Asia Liposomes Drug Delivery Sales, 2016-2027
6.6.3 China Liposomes Drug Delivery Market Size, 2016-2027
6.6.4 Japan Liposomes Drug Delivery Market Size, 2016-2027
6.6.5 South Korea Liposomes Drug Delivery Market Size, 2016-2027
6.6.6 Southeast Asia Liposomes Drug Delivery Market Size, 2016-2027
6.6.7 India Liposomes Drug Delivery Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Liposomes Drug Delivery Revenue, 2016-2027
6.7.2 By Country - South America Liposomes Drug Delivery Sales, 2016-2027
6.7.3 Brazil Liposomes Drug Delivery Market Size, 2016-2027
6.7.4 Argentina Liposomes Drug Delivery Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Liposomes Drug Delivery Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Liposomes Drug Delivery Sales, 2016-2027
6.8.3 Turkey Liposomes Drug Delivery Market Size, 2016-2027
6.8.4 Israel Liposomes Drug Delivery Market Size, 2016-2027
6.8.5 Saudi Arabia Liposomes Drug Delivery Market Size, 2016-2027
6.8.6 UAE Liposomes Drug Delivery Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Gilead Sciences
7.1.1 Gilead Sciences Corporate Summary
7.1.2 Gilead Sciences Business Overview
7.1.3 Gilead Sciences Liposomes Drug Delivery Major Product Offerings
7.1.4 Gilead Sciences Liposomes Drug Delivery Sales and Revenue in Global (2016-2021)
7.1.5 Gilead Sciences Key News
7.2 Pacira
7.2.1 Pacira Corporate Summary
7.2.2 Pacira Business Overview
7.2.3 Pacira Liposomes Drug Delivery Major Product Offerings
7.2.4 Pacira Liposomes Drug Delivery Sales and Revenue in Global (2016-2021)
7.2.5 Pacira Key News
7.3 Sun Pharmaceutical
7.3.1 Sun Pharmaceutical Corporate Summary
7.3.2 Sun Pharmaceutical Business Overview
7.3.3 Sun Pharmaceutical Liposomes Drug Delivery Major Product Offerings
7.3.4 Sun Pharmaceutical Liposomes Drug Delivery Sales and Revenue in Global (2016-2021)
7.3.5 Sun Pharmaceutical Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Liposomes Drug Delivery Major Product Offerings
7.4.4 Johnson & Johnson Liposomes Drug Delivery Sales and Revenue in Global (2016-2021)
7.4.5 Johnson & Johnson Key News
7.5 Luye Pharma
7.5.1 Luye Pharma Corporate Summary
7.5.2 Luye Pharma Business Overview
7.5.3 Luye Pharma Liposomes Drug Delivery Major Product Offerings
7.5.4 Luye Pharma Liposomes Drug Delivery Sales and Revenue in Global (2016-2021)
7.5.5 Luye Pharma Key News
7.6 Sigma-Tau Group
7.6.1 Sigma-Tau Group Corporate Summary
7.6.2 Sigma-Tau Group Business Overview
7.6.3 Sigma-Tau Group Liposomes Drug Delivery Major Product Offerings
7.6.4 Sigma-Tau Group Liposomes Drug Delivery Sales and Revenue in Global (2016-2021)
7.6.5 Sigma-Tau Group Key News
7.7 Ipsen (Onivyde)
7.7.1 Ipsen (Onivyde) Corporate Summary
7.7.2 Ipsen (Onivyde) Business Overview
7.7.3 Ipsen (Onivyde) Liposomes Drug Delivery Major Product Offerings
7.4.4 Ipsen (Onivyde) Liposomes Drug Delivery Sales and Revenue in Global (2016-2021)
7.7.5 Ipsen (Onivyde) Key News
7.8 CSPC
7.8.1 CSPC Corporate Summary
7.8.2 CSPC Business Overview
7.8.3 CSPC Liposomes Drug Delivery Major Product Offerings
7.8.4 CSPC Liposomes Drug Delivery Sales and Revenue in Global (2016-2021)
7.8.5 CSPC Key News
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Corporate Summary
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Liposomes Drug Delivery Major Product Offerings
7.9.4 Teva Pharmaceutical Liposomes Drug Delivery Sales and Revenue in Global (2016-2021)
7.9.5 Teva Pharmaceutical Key News
7.10 Novartis
7.10.1 Novartis Corporate Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Liposomes Drug Delivery Major Product Offerings
7.10.4 Novartis Liposomes Drug Delivery Sales and Revenue in Global (2016-2021)
7.10.5 Novartis Key News
7.11 Fudan-Zhangjiang
7.11.1 Fudan-Zhangjiang Corporate Summary
7.11.2 Fudan-Zhangjiang Liposomes Drug Delivery Business Overview
7.11.3 Fudan-Zhangjiang Liposomes Drug Delivery Major Product Offerings
7.11.4 Fudan-Zhangjiang Liposomes Drug Delivery Sales and Revenue in Global (2016-2021)
7.11.5 Fudan-Zhangjiang Key News
8 Global Liposomes Drug Delivery Production Capacity, Analysis
8.1 Global Liposomes Drug Delivery Production Capacity, 2016-2027
8.2 Liposomes Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global Liposomes Drug Delivery Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Liposomes Drug Delivery Supply Chain Analysis
10.1 Liposomes Drug Delivery Industry Value Chain
10.2 Liposomes Drug Delivery Upstream Market
10.3 Liposomes Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Liposomes Drug Delivery Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Liposomes Drug Delivery in Global Market
Table 2. Top Liposomes Drug Delivery Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Liposomes Drug Delivery Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Liposomes Drug Delivery Revenue Share by Companies, 2016-2021
Table 5. Global Liposomes Drug Delivery Sales by Companies, (K Vial), 2016-2021
Table 6. Global Liposomes Drug Delivery Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Liposomes Drug Delivery Price (2016-2021) & (USD/Vial)
Table 8. Global Manufacturers Liposomes Drug Delivery Product Type
Table 9. List of Global Tier 1 Liposomes Drug Delivery Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposomes Drug Delivery Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type